Search details
1.
A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation.
J Virol
; : e0021324, 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38832789
2.
The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells.
J Gen Virol
; 104(9)2023 09.
Article
in English
| MEDLINE | ID: mdl-37668349
3.
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
mBio
; 15(1): e0247723, 2024 Jan 16.
Article
in English
| MEDLINE | ID: mdl-38054729
4.
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
bioRxiv
; 2023 Apr 21.
Article
in English
| MEDLINE | ID: mdl-37131698
5.
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus.
Antiviral Res
; 209: 105474, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36511318
6.
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Med
; 3(10): 705-721.e11, 2022 10 14.
Article
in English
| MEDLINE | ID: mdl-36044897
Results
1 -
6
de 6
1
Next >
>>